daunorubicin has been researched along with carbocyanines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Buck, S; Ozgen, U; Ravindranath, Y; Savaşan, S | 1 |
| Anagnostopoulos, N; Androutsos, G; Galanopoulos, A; Kalmantis, T; Meletis, J; Paterakis, G; Rombos, Y; Sagriotis, A; Symeonidis, A; Tiniakou, M; Tsimberidou, AM; Yataganas, X; Zoumbos, N | 1 |
| Aubert, D; Bonhomme, A; Millot, JM; Pinon, JM; Sauvage, V | 1 |
| Cooper, EL; Cossarizza, A; Ferraresi, R; Lugli, E; Nasi, M; Pinti, M; Prada, N; Roat, E; Troiano, L | 1 |
| Edwards, BS; Khawaja, HM; Larson, RS; Lovato, DM; Oprea, TI; Sklar, LA; Steele, ID; Winter, SS; Young, SM | 1 |
| Alferova, VA; Borisova, NE; Chistov, AA; Doroshenko, IA; Korshun, VA; Markova, AA; Martynova, EA; Podrugina, TA; Sapozhnikova, KA; Shibaeva, AV; Shuvalov, MV; Svirshchevskaya, EV; Veryutin, DA | 1 |
6 other study(ies) available for daunorubicin and carbocyanines
| Article | Year |
|---|---|
Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.
Topics: Annexin A5; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carbocyanines; Child; Cytarabine; Daunorubicin; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Indicators and Reagents; Leukemia; Propidium; T-Lymphocytes; Tumor Cells, Cultured; U937 Cells; Vincristine | 2000 |
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Calcium Channel Blockers; Carbocyanines; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Fluoresceins; Fluorescent Dyes; Genistein; Humans; Idarubicin; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; Prognosis; Prospective Studies; Rhodamine 123; Survival Analysis; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles; Verapamil | 2002 |
P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Transport, Active; Carbocyanines; Cell Line; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Fluorescent Dyes; Humans; Membrane Transport Proteins; Protozoan Proteins; Toxoplasma; Vacuoles; Verapamil; Xenobiotics | 2004 |
Characterization of cells with different mitochondrial membrane potential during apoptosis.
Topics: Apoptosis; Benzimidazoles; Carbocyanines; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Daunorubicin; DNA; DNA Fragmentation; Doxorubicin; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Intracellular Membranes; Leukocytes, Mononuclear; Membrane Potentials; Mitochondria; Phosphatidylserines; Quercetin; U937 Cells | 2005 |
High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Carbocyanines; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Mometasone Furoate; Pregnadienediols; Up-Regulation | 2008 |
Probing tricarbocyanine dyes for targeted delivery of anthracyclines.
Topics: Alkynes; Anthracyclines; Azides; Carbocyanines; Click Chemistry; Daunorubicin; Fluorescent Dyes | 2023 |